ANTIBIOTIC-THERAPY OF PERFORATED APPENDIC ITIS IN CHILDREN - A COMPARISON OF AMOXICILLIN-CLAVULANATE WITH A COMBINATION OF BENZYLPENICILLIN, NETILMICIN AND METRONIDAZOLE
M. Schmitt et al., ANTIBIOTIC-THERAPY OF PERFORATED APPENDIC ITIS IN CHILDREN - A COMPARISON OF AMOXICILLIN-CLAVULANATE WITH A COMBINATION OF BENZYLPENICILLIN, NETILMICIN AND METRONIDAZOLE, Pediatrie, 48(9), 1993, pp. 633-637
In a multicentre trial we compared the clinical efficacy of amoxicilli
n/clavulanate used as a single-agent therapy with that of the three-ag
ent combination usually prescribed in the post-operative period for ap
pendicular peritonitis in children. Only bacteriologically documented
peritoneal infections were included. Sixty-four patients were randomly
distributed between two groups: Group A (29 cases) treated with amoxi
cillin/clavulanate, first administered iv (100 mg/kg/d), followed by c
onversion to the oral route (50 mg/kg/d) once the patient had been afe
brile for 48 hours; Group B (35 cases) first treated by the iv route w
ith benzylpenicillin (100,000 IU/kg/d) plus netilmicin (5 mg/kg/d) plu
s metronidazole (30 mg/kg/d), followed by conversion to the oral route
for metronidazole (30 mg/kg/d). In both groups, the total duration of
parenteral and oral treatment was not less than 5 days. One hundred a
nd seventy nine bacterial strains were recovered from peritoneal fluid
samples obtained during surgery; 86% of these were sensitive to amoxi
cillin/clavulanate. Clinical efficacy, assessed on the basis of time u
ntil return to normal temperature and gut transit and duration of hosp
italization, was identical in both groups, with follow-up monitoring o
n day 30 showing recovery in all cases. Cure was obtained without any
problems of infection in 25/29 patients in group A and in 34/35 patien
ts in group B (non significant difference). Tolerance was excellent an
d identical in the two groups with the exception of three cases of thr
ombophlebitis which occurred in group B. The results of this study sug
gest that amoxicillin/clavulanate may be useful as single-agent therap
y as a first-line curative treatment for appendicular peritonitis in c
hildren.